Hot Investor Mandate 4: Global Pharma Firm Seeks Assets in Oncology, Neurology, Cardio, Respiratory and Infectious Diseases

6 Jul

A major Chinese pharmaceutical company is looking for any potential drug candidates that align with the company’s strategy. The firm is seeking to strengthen its R&D/manufacturing capability and portfolio/pipeline and is open to all kinds of collaboration models, including straight licensing, co-development, contract selling, equity investment, and M&A. The company is currently looking for assets globally with a focus on the US and Europe.

Early stage products or platform technology with high potential or clear differentiation in the following areas: Oncology, Neurology, Cardiovascular & Cerebrovascular, Rheumatology and Inflammation, Respiratory Diseases, Infectious Diseases (except HIV), and Pediatric Diseases (except rare disease).  In addition, the firm is exploring emerging areas in oncology, such as immunotherapy, cell therapy, and precision medicine. In medical technology, the firm is interested in liquid biopsy, cancer diagnostics, and next generation sequencing, and would consider in-development and products.

The firm is looking for companies with capacity and experience in implementing R&D plans. The firm is interested in assets from the US, Europe or other countries, and intends to introduce the product to the Chinese market.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: